-+ 0.00%
-+ 0.00%
-+ 0.00%

Stephens & Co. Reiterates Equal-Weight on Amedisys, Maintains $101 Price Target

Benzinga·03/04/2025 13:48:19
Listen to the news
Stephens & Co. analyst Scott Fidel reiterates Amedisys (NASDAQ:AMED) with a Equal-Weight and maintains $101 price target.